Anzeige
Mehr »
Sonntag, 06.07.2025 - Börsentäglich über 12.000 News
Surfen Sie die heißeste Edelmetall-Welle des Jahrzehnts! Dieses TOP-Unternehmen zündet nächste Wachstumsstufe!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
260 Leser
Artikel bewerten:
(1)

LeadsRx and WideOrbit Partnership Gives Advertisers Access to Advertising Campaign Data to Maximize ROAS

PORTLAND, OR / ACCESSWIRE / March 10, 2020 / LeadsRx today further strengthens its unrivaled marketing attribution SaaS platform for marketers by partnering with WideOrbit, a leading provider of advertising management technology for media companies and broadcasters. By combining LeadsRx and WideOrbit's powerful technology offerings, LeadsRx customers will benefit from the automated and accurate delivery of broadcast advertising data, while WideOrbit customers will be able to tap into impartial multi-touch attribution capabilities across multiple advertising channels.

Now, marketers can easily incorporate broadcast advertising into cross-channel attribution models to see how all mediums contribute to customer acquisition. Such models aid marketers in identifying high-valued campaigns and potentially wasted ad-spend in order to optimize spend allocation and maximize Return on Ad Spend (ROAS).

With an API connection to WideOrbit's technology, LeadsRx solves a major problem by making broadcast data easily available without the need for searching, manual uploads, or formatting special files. Necessary spot data can now be made available to advertisers automatically, updated daily. This is critically important because broadcast advertising spot inventory is limited, and there is often a competitive race between advertisers vying for the same target audience.

The LeadsRx and WideOrbit partnership helps advertisers quickly identify the best advertising dayparts, days, and other attributes, giving them a competitive edge in obtaining their preferred spots.

"By partnering with WideOrbit, LeadsRx is disrupting the game for marketers by making broadcast ad campaign data readily and equally accessible to all," said AJ Brown, CEO and co-founder of LeadsRx. "LeadsRx gives pioneering marketers instant access to the data they need to develop predictive intelligence to implement effective campaign strategies, rapidly make changes to dial-in campaigns to better target audiences, and use ad dollars more effectively in the future."

Broadcast advertising is a channel that has historically been slow and difficult to optimize. Data insights were often not available at all or were only available after an advertising campaign had concluded - leaving marketers with no opportunity to optimize their advertising campaigns without having to ride out what might be a potentially ineffective campaign. In fact, some broadcasters do not even provide the actual time a spot aired, or if they do, it's buried within a PDF file on the advertiser invoice and requires significant effort to extract.

WideOrbit has a variety of TV and radio advertising solutions and clients, across multiple channels, including WO Traffic, WO Network, WO Digital, WO Streaming, and WO On Demand. This partnership broadens the cross-channel scope of LeadsRx marketing attribution software by easily bringing in data from broadcast sources around the world. In addition, it strengthens LeadsRx capabilities in the area of segmentation analysis, A/B testing of broadcast creatives, return-on-ad-spend analysis, and lift reporting.

"Our partnership with LeadsRx adds an important piece of the puzzle for WideOrbit customers," said Tim Swift, WideOrbit COO and acting VP, Integrations. "In addition to helping improve mid-campaign performance analysis and optimization, the ability to give TV advertising appropriate attribution for driving customer acquisition across channels is potentially game-changing for broadcasters, allowing them to better demonstrate value to advertisers and drive new demand."

Integrating WideOrbit's technology with LeadsRx marketing attribution allows WideOrbit customers the ability to perform marketing attribution, a way to connect the dots between advertising campaigns and business outcomes like customer acquisition. By making this information available to marketers, campaigns can be analyzed on a daily basis, as opposed to after the campaign has run its course, improving speed, efficiency and pace of iteration for WideOrbit clients. The impartial insights derived from the marketing data help advertisers to be more effective at delegating resources toward marketing channels that provide the highest ROAS.

About LeadsRx

A fast innovator and a marketer's choice for 3,500-plus global and local brands, LeadsRx is an unrivaled multi-touch attribution SaaS platform. Powered by a unique Universal Conversion Tracking Pixel™,

LeadsRx provides an impartial view of customer journeys, giving each advertising touchpoint proper weight and credit including broadcast media. Founded by marketers, LeadsRx enables companies of any size to elevate marketing performance in a framework that is easily understood delivering sustainable return on ad spend (ROAS). To learn more about how LeadsRx can support you in marketing transformation visit LeadsRx.com. Connect with LeadsRx on Twitter, LinkedIn and Facebook.

About WideOrbit

WideOrbit is the technology platform for media companies to connect audiences and ads, everywhere. Our mission is to simplify media buying and selling by focusing on innovation, customer delight, and value creation for both sides of media transactions. Starting with our core traffic management solution, WideOrbit centralizes digital and linear advertising operations and streamlines workflows for radio, cable, and television companies.

WideOrbit is headquartered in San Francisco with offices worldwide. Customers include NBCUniversal, Tribune Media, Entercom Communications, Hearst, Univision, Nexstar, Gray Television, TEGNA, AMC Networks, and many other top media companies around the world.

For press inquiries, please contact media@widedorbit.com.

For more information

Jeff Fishburn
Fishburn PR for LeadsRx
+1 (503) 799-1988
jeff@fishburnpr.com

SOURCE: LeadsRx



View source version on accesswire.com:
https://www.accesswire.com/579420/LeadsRx-and-WideOrbit-Partnership-Gives-Advertisers-Access-to-Advertising-Campaign-Data-to-Maximize-ROAS

© 2020 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.